Sponsored by Biotest, the highly anticipated third module of the Management of CMV in Solid Organ Transplant Patients course is now open for registration. Titled The Future of CMV Management, this module promises cutting-edge insights into advancements in CMV immunotherapy and vaccination for transplant patients.
Learning Objectives
Participants will:
- Explore the evolving landscape of CMV immunotherapy and vaccination strategies.
- Gain an understanding of the role of cell-mediated immunity in guiding clinical decisions to enhance transplant outcomes.
- Stay informed about upcoming research and potential breakthroughs in CMV management.
Lectures
CMV Cell-Mediated Immunity in Clinical Practice by Hannah Kaminski, Bordeaux University Hospital, France
CMV Immunotherapy and Vaccine by Lionel Couzi, Bordeaux University, CNRS, ImmunoConcEpT, France and Rajiv Khanna, QIMR Berghofer Medical Research Institute, Queensland, Australia
This module is an excellent opportunity for transplant professionals to learn from leading experts, gain insights into the future of CMV management, and engage with cutting-edge research in the field. Register now to be part of this transformative learning experience!
Access this valuable resource for free if you’re an ESOT member. Visit Transplant Live to start learning today!
Special thanks to Biotest for supporting this initiative.
